Top Markets
Coin of the day
EXoZymes, Inc. EXoZymes, Inc.

EXoZymes, Inc.

EXOZ
Rank in Stocks #23841
eXoZymes, Inc. operates as a development stage biotechnology company. It... eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
Share Price
$7.38
Last synced: 2026-08-21
Market Cap
$68.45M
Change (1 day)
4.76%
Change (1 year)
-20.78%
Country
US
Trade EXoZymes, Inc. (EXOZ)

Category

P/B ratio for EXoZymes, Inc. (EXOZ)
P/B ratio as of 2026 TTM: 0
According to EXoZymes, Inc. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for EXoZymes, Inc. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
6.3419 -
US
6.2413 -
NL
3.7087 -
US
2.5054 -
AU
- -
CH